PTH1R and hypercalcemia disease: Although the ability of orthosteric modulators to reverse the effect of cPTH in PHPT patients needs to be further investigated in clinical practice, the direct deactivation of the PTH1R seems to be particularly useful in treating hypercalcemia associated with PHPT, especially in cases of life-threatening hypercalcemic crisis.